Human Growth Hormone

Human Growth Hormone

• Home
• What is HGH?
• Search
• Syndicate
• More Health

See Also

Human Growth Hormone > Human Growth Hormone > Dublin

Please select a HGH news story from the list below:

• Business Wire - An Essential Competitor Analysis Report on Human Growth Hormones : Biosimilar Pricing is Not Enough, Convenience Will Mandate
• Business Wire - Research and Markets: Natural-Based Polymers for Biomedical Applications Reviews the Wealth of Research on Both Tried and Promising New Natural-Based...
• Business Wire - Competitor Analysis: Biogenerics & Therapeutic Proteins
• Business Wire - New Report Details the Dynamics of the Global Cytology and HPV Testing Markets
• Business Wire - New Report Gives an Introduction to Blood Components and Blood Plasma Proteins
• Business Wire - Introducing the Brand New Report on Business Strategies for Different Types of Biogenerics
• Business Wire - FibroGen Announces New Research in HIF and CTGF Therapeutic Programs Presented at the Annual Meeting of the American Society of Nephrology
• Business Wire - Research and Markets: If the Biosimilar Industry is Going to Progress beyond the First Generation Biologics Then It Needs to Target More High Profile Therapies
• Business Wire - The Development of Biosimilars for a Range of Recombinant Protein Classes is Becoming Increasingly Attractive According to New Research Report
• Business Wire - Research and Markets: Apotex Generics Company Intelligence Report Brings You the New up to Date Developments within This Generics Company

Business Wire - An Essential Competitor Analysis Report on Human Growth Hormones : Biosimilar Pricing is Not Enough, Convenience Will Mandate

October 8, 2008 -- DUBLIN, Ireland -- Research and Markets (http://www.researchandmarkets.com/research/6c5438/competitor_analysi) has announced the addition of the...

• Business Wire - An Essential Competitor Analysis Report on Human Growth Hormones : Biosimilar Pricing is Not Enough, Convenience Will Mandate

Business Wire - Research and Markets: Natural-Based Polymers for Biomedical Applications Reviews the Wealth of Research on Both Tried and Promising New Natural-Based...

July 2, 2008 -- DUBLIN, Ireland -- Research and Markets (http://www.researchandmarkets.com/research/5ca569/naturalbased_poly) has announced the addition of the...

• Business Wire - Research and Markets: Natural-Based Polymers for Biomedical Applications Reviews the Wealth of Research on Both Tried and Promising New Natural-Based...

Business Wire - Competitor Analysis: Biogenerics & Therapeutic Proteins

June 25, 2008 -- DUBLIN, Ireland -- Research and Markets (http://www.researchandmarkets.com/research/2f8661/competitor_analysi) has announced the addition of the...

• Business Wire - Competitor Analysis: Biogenerics & Therapeutic Proteins

Business Wire - New Report Details the Dynamics of the Global Cytology and HPV Testing Markets

June 23, 2008 -- DUBLIN, Ireland -- Research and Markets (http://www.researchandmarkets.com/research/d5568c/cytology_and_hpv_t) has announced the addition of the...

• Business Wire - New Report Details the Dynamics of the Global Cytology and HPV Testing Markets

Business Wire - New Report Gives an Introduction to Blood Components and Blood Plasma Proteins

March 12, 2008 -- DUBLIN, Ireland -- Research and Markets (http://www.researchandmarkets.com/reports/c85621) has announced the addition of Human Blood Plasma Proteins:...

• Business Wire - New Report Gives an Introduction to Blood Components and Blood Plasma Proteins

Business Wire - Introducing the Brand New Report on Business Strategies for Different Types of Biogenerics

December 6, 2007 -- DUBLIN, Ireland -- Research and Markets (http://www.researchandmarkets.com/reports/c76537) has announced the addition of new Decision Resources...

• Business Wire - Introducing the Brand New Report on Business Strategies for Different Types of Biogenerics

Business Wire - FibroGen Announces New Research in HIF and CTGF Therapeutic Programs Presented at the Annual Meeting of the American Society of Nephrology

November 7, 2007 -- SAN FRANCISCO -- FibroGen, Inc. today announced data from research on its therapeutic programs targeting hypoxia-inducible factor prolyl hydroxylase...

• Business Wire - FibroGen Announces New Research in HIF and CTGF Therapeutic Programs Presented at the Annual Meeting of the American Society of Nephrology

Business Wire - Research and Markets: If the Biosimilar Industry is Going to Progress beyond the First Generation Biologics Then It Needs to Target More High Profile Therapies

October 26, 2007 -- DUBLIN, Ireland -- Research and Markets (http://www.researchandmarkets.com/reports/c72832) has announced the addition of new report from Espicom...

• Business Wire - Research and Markets: If the Biosimilar Industry is Going to Progress beyond the First Generation Biologics Then It Needs to Target More High Profile Therapies

Business Wire - The Development of Biosimilars for a Range of Recombinant Protein Classes is Becoming Increasingly Attractive According to New Research Report

August 23, 2007 -- DUBLIN, Ireland -- Research and Markets (http://www.researchandmarkets.com/reports/c66404) has announced the addition of

• Business Wire - The Development of Biosimilars for a Range of Recombinant Protein Classes is Becoming Increasingly Attractive According to New Research Report

Business Wire - Research and Markets: Apotex Generics Company Intelligence Report Brings You the New up to Date Developments within This Generics Company

August 7, 2007 -- DUBLIN, Ireland -- Research and Markets (http://www.researchandmarkets.com/reports/c31925) has announced the addition of the Espicom Business...

• Business Wire - Research and Markets: Apotex Generics Company Intelligence Report Brings You the New up to Date Developments within This Generics Company

Cities

dublin natural san francisco

Country

ireland